title: Violating the theory of single gene-single disorder: inhibitor development in hemophilia.
abstract: Hemophilia is clinically and genetically heterogeneous blood disorder with several known gene defects accounting for the diversity of disease phenotype and inhibitor production. Although increasing number of causative mutations have been reported, not much is known regarding the root cause of inhibitor development against infused blood clotting factors, which represents a major challenge in the treatment of disease. The variations in the severity and frequency of bleeding in hemophiliacs with same molecular defect, indicates the role of modifier genes in the pathogenesis of disease. Herein, we aim to review and summarise the literature over the past decade, to gain insight into what is critical for the development of inhibitors in hemophilia. Aside from potential mutations in factor VIII and IX, polymorphisms in various genes such as human leukocyte antigen-I (HLA-I), HLA-II, tumor necrosis factor-alpha, interleukin-10 and cytotoxic T-lymphocyte associated antigen-4, also tends to contribute to the development of inhibitors. Violating the theory of single gene-single disorder, new research indicates that inhibitor arise from a complex interplay of multiple genetic, immunological and environmental factors. With the revolutionary advances in whole genome sequencing, we propose a detailed genome wide study to identify the spectrum of genetic markers involved in the development of inhibitors for better diagnostics and therapeutics.
authors.affiliation: Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Kuwait University, 31470, Sulaibekhat, Kuwait.
authors.forename: Suad
authors.initials: S
authors.lastname: AlFadhli
authors.affiliation: Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Kuwait University, 31470, Sulaibekhat, Kuwait.
authors.forename: Rasheeba
authors.initials: R
authors.lastname: Nizam
keywords: Hemophilia; Inhibitors; Mutations; Polymorphisms
references.citation: Haemophilia. 2006 Jul;12(4):398-400
references.pmid: 16834740
references.citation: Thromb Haemost. 1999 Aug;82(2):500-4
references.pmid: 10605742
references.citation: Lancet. 1992 Mar 7;339(8793):594-8
references.pmid: 1347102
references.citation: Blood. 2006 Apr 15;107(8):3167-72
references.pmid: 16380445
references.citation: Mol Pathol. 2002 Apr;55(2):127-44
references.pmid: 11950963
references.citation: Thromb Haemost. 1998 Feb;79(2):452-3
references.pmid: 9493612
references.citation: Br J Haematol. 1990 Oct;76(2):238-41
references.pmid: 2128808
references.citation: Thromb Haemost. 2007 May;97(5):788-94
references.pmid: 17479189
references.citation: Haemophilia. 2006 Dec;12 Suppl 6:15-22
references.pmid: 17123389
references.citation: J Thromb Haemost. 2013 Jul;11(7):1329-40
references.pmid: 23617593
references.citation: Blood. 2006 Dec 1;108(12):3739-45
references.pmid: 16926287
references.citation: Thromb Haemost. 2010 Jul;104(1):78-85
references.pmid: 20431853
references.citation: Turk J Haematol. 2012 Mar;29(1):34-9
references.pmid: 24744621
references.citation: Blood. 2013 Feb 21;121(8):1446-54
references.pmid: 23223434
references.citation: Chin Med J (Engl). 2010 Feb 5;123(3):305-10
references.pmid: 20193250
references.citation: Transfus Med Rev. 1987 Dec;1(3):161-70
references.pmid: 2980275
references.citation: Int J Hematol. 2010 Jun;91(5):784-91
references.pmid: 20533009
references.citation: J Thromb Haemost. 2009 Dec;7(12):2006-2015
references.pmid: 19817985
references.citation: Int J Immunogenet. 2010 Apr;37(2):79-82
references.pmid: 20082647
references.citation: J Pharm Sci. 2012 Jan;101(1):48-55
references.pmid: 21953409
references.citation: J Med Virol. 2013 Jun;85(6):1009-18
references.pmid: 23591975
references.citation: Haemophilia. 2011 Jul;17(4):641-9
references.pmid: 21362111
references.citation: Clin Appl Thromb Hemost. 2011 Aug;17(4):358-61
references.pmid: 20460344
references.citation: Rev Bras Hematol Hemoter. 2013;35(4):280-6
references.pmid: 24106448
references.citation: J Thromb Haemost. 2007 Feb;5(2):263-5
references.pmid: 17269936
references.citation: Haematologica. 2008 May;93(5):722-8
references.pmid: 18387975
references.citation: Thromb Haemost. 2013 Dec;110(6):1114-20
references.pmid: 24008306
references.citation: Haematologica. 2005 Jul;90(7):924-31
references.pmid: 15996930
references.citation: Thromb Haemost. 2012 Jan;107(1):30-6
references.pmid: 22116520
references.citation: Lancet. 2003 May 24;361(9371):1801-9
references.pmid: 12781551
references.citation: Tissue Antigens. 1999 Jul;54(1):91-7
references.pmid: 10458328
references.citation: J Thromb Haemost. 2005 Aug;3(8):1676-81
references.pmid: 16102033
references.citation: Clin Exp Immunol. 2010 Dec;162(3):425-37
references.pmid: 20846164
references.citation: Haemophilia. 2010 Sep 1;16(5):791-800
references.pmid: 20331761
references.citation: J Immunol. 2005 Apr 15;174(8):4718-26
references.pmid: 15814696
references.citation: Thromb Haemost. 1997 Feb;77(2):234-7
references.pmid: 9157572
references.citation: Haemophilia. 2010 May;16(3):538-44
references.pmid: 20236351
references.citation: Haemophilia. 2002 Mar;8 Suppl 2:23-9
references.pmid: 11966849
references.citation: Nucleic Acids Res. 2009 Jan;37(Database issue):D412-6
references.pmid: 18940858
references.citation: Adv Exp Med Biol. 1995;386:47-63
references.pmid: 8851014